Automation of Liquid Nitrogen Freezer for Cryopreservation of Unique Human Biospecimens at the Vanderbilt Biospecimen Storage Facility
Automation of Liquid Nitrogen Freezer for Cryopreservation of Unique Human Biospecimens at the Vanderbilt Biospecimen Storage Facility
批准号:
10736276
负责人:
Alexander Bick
金额:
$25.28万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-08-01 至 2024-07-31
关键词:
Academic Medical CentersAccelerationAutomationAutomobile DrivingAwardBasic ScienceBiologicalBiological MarkersBiological SciencesCOVID-19 pandemicCOVID-19 patientCOVID-19 preventionCanadaClinicClinicalClinical ResearchClinical SciencesCollectionCooperative Human Tissue NetworkCryopreservationDataDiseaseDisease ProgressionEnsureEnvironmentFriendsFundingFutureGeneticGenotypeGlassHumanIndividualInfrastructureInstitutionInternationalInvestigationInvestmentsLinkLiquid substanceMonitorMonoclonal AntibodiesNational Cancer InstituteNitrogenPhenotypeReagentRecoveryResearch PersonnelResource SharingResourcesRetrievalRiskRoboticsSARS-CoV-2 antibodySafetySamplingServicesSpecimenSystemTechnologyTemperatureTissue SampleTissuesTransition TemperatureTranslational ResearchTranslationsUnited StatesUnited States National Institutes of HealthVaccinesWaterWithdrawalanimal tissueanticancer researchbiobankcancer carecell preparationcostcost effectivecryogenicsdisorder riskhigh dimensionalityhuman diseasehuman tissueimprovedmigrationpersonalized medicinepreservationrepositorytreatment responsevaccinology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Large, high-dimensional clinical, genetic and biomarker data linked to bio-repositories are driving basic, clinical
and translational research. For the past 20 years, Vanderbilt University Medical Center (VUMC) has made
long-term strategic investments in translational sciences as a platform for excellence across clinical and basic
science departments and is internationally recognized as a leader in such fields as personalized medicine,
vaccinology, and cancer care and research. As examples, BioVU, Vanderbilt’s large-scale biorepository,
contains detailed de-identified human phenotype information linked to de-identified discarded samples and
genotypes. Viably cryopreserved human specimens enabled the Vanderbilt Vaccine Center to isolate
monoclonal antibodies against COVID-19 that were developed into Evusheld, a therapy to prevent COVID-19
in at-risk individuals. Cooperative Human Tissue Network at VUMC is one of only six funded by the National
Cancer Institute to procure and distribute human tissues to researchers throughout the US, Canada, and
internationally. These resources and others provide an accelerating engine of discovery. Collectively these
endeavors are providing powerful predictors of disease risk, disease progression or response to therapy and
underpinning studies delineating the fundamental mechanism of disease as well as translation to the clinic.
These large-scale initiatives generate a massive number of valuable human and animal tissue samples. These
tissues can only be viably cryopreserved when stored in liquid nitrogen. The size of these biorepositories is
exceeding the capacity of individual investigators or groups to effectively curate, maintain sample integrity and
rapidly retrieve samples for further study. Many of these materials could not be replaced and are of
international importance. To meet this large and growing need, a specialized automated -190°C Cryogenic
Freezer for Sample Storage system is necessary to manage, store and retrieve the tens of thousands of
biorepository samples. This proposal seeks to obtain funding for the purchase of an Azenta BioStore Cryo M60
robotic liquid nitrogen freezer system that can accommodate all large biorepositories at Vanderbilt. With such a
system Vanderbilt can provide the necessary institutional support, environment and expertise to ensure cost-
effective, quality assured management, storage and retrieval of these critical samples and reagents. The
technology is durable and scalable and therefore it can be predicted that this automated system will enable a
broad range of investigators and propel basic, clinical and translational research long into the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
-
批准号:10638404
-
项目类别:
-
资助金额:$81.76万
-
财政年份:2023
-
负责人:Alexander Bick
-
依托单位:
Targeting Clonal Hematopoiesis of Indeterminate Potential Using Human Genetics
-
批准号:10378932
-
项目类别:
-
资助金额:$2.09万
-
财政年份:2021
-
负责人:Alexander Bick
-
依托单位:
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics
-
批准号:10016727
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2020
-
负责人:Alexander Bick
-
依托单位:
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics
-
批准号:10685925
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2020
-
负责人:Alexander Bick
-
依托单位:
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics
-
批准号:10480770
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2020
-
负责人:Alexander Bick
-
依托单位:
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics
-
批准号:10263942
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2020
-
负责人:Alexander Bick
-
依托单位:
海外基金